Fat loss and body composition optimization require targeting the biological mechanisms that regulate energy balance, fat storage, and muscle preservation. Modern peptide therapies and hormone optimization offer clinically validated tools for sustainable results.
How These Compounds Help
Tirzepatide and semaglutide are GLP-1 receptor agonists (tirzepatide also targets GIP receptors) that reduce appetite, slow gastric emptying, and improve insulin sensitivity. Clinical trials demonstrate significant, sustained fat loss with preservation of lean mass when combined with adequate protein intake and resistance training.
Tesamorelin takes a targeted approach by stimulating natural growth hormone release, which preferentially mobilizes visceral fat — the metabolically dangerous fat surrounding organs. It is the only FDA-approved therapy specifically for visceral fat reduction.
Testosterone optimization supports fat loss by improving metabolic rate, increasing lean mass, and reducing fat accumulation driven by hypogonadism. The combination of TRT with peptide therapies can produce superior body composition outcomes.
Who This Is For
This goal category is relevant for individuals seeking:
- Clinically significant fat loss (10%+ body weight reduction)
- Visceral fat reduction for metabolic health improvement
- Body recomposition (losing fat while preserving or gaining muscle)
- Appetite regulation and sustainable caloric deficit support
- Improved body composition metrics (body fat %, waist circumference)
Body Composition Tracking
Effective fat loss protocols should track:
- Body weight and body fat percentage (DEXA scan preferred)
- Waist circumference as a proxy for visceral fat
- Lean mass to ensure muscle preservation during fat loss
- Metabolic markers including fasting insulin, triglycerides, and inflammatory markers
- Hormonal status including testosterone, thyroid, and cortisol levels